Heritage Way Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$200K Hold
25,000
0.07% 69
2021
Q3
$483K Sell
25,000
-9,000
-26% -$157K 0.2% 60
2021
Q2
$469K Hold
34,000
0.19% 60
2021
Q1
$307K Sell
34,000
-7,712
-18% -$56.4K 0.13% 62
2020
Q4
$230K Hold
41,712
0.11% 64
2020
Q3
$135K Hold
41,712
0.07% 64
2020
Q2
$135K Hold
41,712
0.08% 61
2020
Q1
$94K Buy
41,712
+10,000
+32% +$45.8K 0.07% 59
2019
Q4
$139K Buy
31,712
+1,712
+6% +$8.05K 0.08% 60
2019
Q3
$153K Buy
30,000
+5,000
+20% +$29.1K 0.1% 59
2019
Q2
$180K Hold
25,000
0.11% 59
2019
Q1
$131K Buy
+25,000
New +$122K 0.09% 58
2018
Q4
Sell
-12,000
Closed -$49K 64
2018
Q3
$49K Hold
12,000
0.03% 60
2018
Q2
$47K Hold
12,000
0.03% 62
2018
Q1
$40K Sell
12,000
-4,000
-25% -$25.3K 0.03% 59
2017
Q4
$110K Sell
16,000
-12,000
-43% -$83.2K 0.08% 65
2017
Q3
$180K Sell
28,000
-4,101
-13% -$26.3K 0.15% 60
2017
Q2
$197K Buy
+32,101
New +$235K 0.17% 57

Other funds holding PLXP

Heritage Way Advisors's PLXP Position: Q4 2021 in Review

Heritage Way Advisors held its PLx Pharma Inc. Common Stock (PLXP) position steady in Q4 2021 at 25,000 shares worth $200K. The position accounts for 0.07% of the portfolio, ranked #69.

Heritage Way Advisors first reported a position in PLXP in Q2 2017 and has held it in 18 quarters since. The position peaked at $483K in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • Heritage Way Advisors held 25,000 shares of PLx Pharma Inc. Common Stock worth $200K as of Q4 2021.
  • Heritage Way Advisors left its PLx Pharma Inc. Common Stock share count unchanged in Q4 2021.
  • PLx Pharma Inc. Common Stock made up 0.07% of Heritage Way Advisors's portfolio in Q4 2021, its #69 holding.
  • Heritage Way Advisors first reported a position in PLx Pharma Inc. Common Stock in Q2 2017 and has held it in 18 quarters since.
  • Heritage Way Advisors's PLx Pharma Inc. Common Stock position peaked at $483K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on Heritage Way Advisors's 13F filing for Q4 2021, filed 13 Jan 2022.